Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

4-bromophenylacetylurea

Known as: p-bromophenylacetylurea 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe incorporationin vivo of14C-glycine into proteins has been studied during the period before and after the onset of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2004
2004
The composition of retrogradely transported axonal proteins was examined by acrylamide gel electrophoresis and gel… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
2000
2000
p-Bromophenylacetylurea (BPAU)-induced delayed neuropathy showed an age-dependent susceptibility in rats. This study investigated… Expand
2000
2000
1. This study has investigated absorption, distribution, metabolism and excretion of p-bromophenylacetylurea (BPAU) in the F344… Expand
1999
1999
This study investigated the neurotoxic potentiation and metabolic interaction between p-bromophenylacetylurea (BPAU) and… Expand
1999
1999
This study presents a HPLC method for the separation and purification of p-bromophenylacetylurea (BPAU) and its metabolites. The… Expand
1986
1986
A structure-activity study was performed to investigate the mechanism of neurotoxicity induced in rats by treatment with p… Expand
1985
1985
Behavioral toxic effects caused by a relatively small dose of the "peripheral" neurotoxin, p-bromophenylacetylurea (BPAU), and of… Expand
Review
1982
Review
1982
Applications of pulse-labeling techniques to the study of axonal transport have provided new insights into certain types of… Expand
1968
1968
In 1960, Diezel and Quadbeck reported that parabromophenylacetylurea, when given to rats by mouth in a single dose of 200 mg/kg… Expand